Arthrogryposis multiplex congenita-whistling face syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1150OMIM:208155Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Arthrogryposis multiplex congenita-whistling face syndrome, also known as Freeman-Sheldon syndrome (FSS) or distal arthrogryposis type 2A (DA2A) or craniocarpotarsal dystrophy, is a rare genetic disorder characterized by the combination of multiple joint contractures (arthrogryposis) and distinctive facial features. The hallmark facial appearance includes a very small, pursed mouth that resembles a whistling expression, prominent nasolabial folds, a small nose, deep-set eyes, and an H-shaped dimpling of the chin. The condition primarily affects the musculoskeletal system, with contractures most commonly involving the hands (clenched fists with ulnar deviation), feet (clubfoot or talipes equinovarus), and other joints. Patients may also experience restricted movement of the shoulders, elbows, hips, and knees. Additional features can include short stature, scoliosis or kyphosis, difficulty swallowing and feeding (particularly in infancy), speech difficulties due to the small oral opening (microstomia), and respiratory complications. Intelligence is typically normal, though developmental delays may occur secondary to physical limitations. Some patients experience malignant hyperthermia susceptibility during anesthesia, which is an important consideration for surgical planning. Treatment is multidisciplinary and primarily supportive. Surgical interventions may be needed to correct joint contractures, clubfoot, scoliosis, and to improve oral opening. Physical and occupational therapy are essential to maximize joint mobility and functional independence. Speech therapy may be beneficial for those with communication difficulties. Craniofacial surgery can address the restrictive facial features. Genetic counseling is recommended for affected families. The condition is caused by mutations in the MYH3 gene, which encodes embryonic myosin heavy chain, playing a critical role in fetal muscle development.

Also known as:

Clinical phenotype terms— hover any for plain English:

Whistling appearanceHP:0000346Abnormal shoulder morphologyHP:0003043Pierre-Robin sequenceHP:0000201
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Arthrogryposis multiplex congenita-whistling face syndrome.

View clinical trials →

No actively recruiting trials found for Arthrogryposis multiplex congenita-whistling face syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Arthrogryposis multiplex congenita-whistling face syndrome community →

No specialists are currently listed for Arthrogryposis multiplex congenita-whistling face syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Arthrogryposis multiplex congenita-whistling face syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Arthrogryposis multiplex congenita-whistling face syndromeForum →

No community posts yet. Be the first to share your experience with Arthrogryposis multiplex congenita-whistling face syndrome.

Start the conversation →

Latest news about Arthrogryposis multiplex congenita-whistling face syndrome

No recent news articles for Arthrogryposis multiplex congenita-whistling face syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Arthrogryposis multiplex congenita-whistling face syndrome

What is Arthrogryposis multiplex congenita-whistling face syndrome?

Arthrogryposis multiplex congenita-whistling face syndrome, also known as Freeman-Sheldon syndrome (FSS) or distal arthrogryposis type 2A (DA2A) or craniocarpotarsal dystrophy, is a rare genetic disorder characterized by the combination of multiple joint contractures (arthrogryposis) and distinctive facial features. The hallmark facial appearance includes a very small, pursed mouth that resembles a whistling expression, prominent nasolabial folds, a small nose, deep-set eyes, and an H-shaped dimpling of the chin. The condition primarily affects the musculoskeletal system, with contractures mos

How is Arthrogryposis multiplex congenita-whistling face syndrome inherited?

Arthrogryposis multiplex congenita-whistling face syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Arthrogryposis multiplex congenita-whistling face syndrome typically begin?

Typical onset of Arthrogryposis multiplex congenita-whistling face syndrome is neonatal. Age of onset can vary across affected individuals.